We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Orijinal İlaç, Eşdeğer İlaç Tartişmalari Üzerine.
- Authors
Çetin, Mesut; Arıcıoğlu, Feyza
- Abstract
The original drugs are protected by the world's most powerful patent protection laws for a certain period of time and sonar equivalent (generic) drugs may be manifactured at the end of the patent protection period. Generic drugs are not only pharmaceutical drugs equivalent to the original generic drugs, but they should also be bioequivalent. Countries who want to reduce health costs, may provide significant savings by using generics. Generic drugs are usually 20-80% cheaper than the originals. It has been announced that TL 3 billion 879 million was saved from the total health expenditures between the years 2004-2008 with the use of generics. Since it is planned that the general health insurance system will eventuate and therefore the health system will cover almost all the population, the use of generic drugs which are much cheaper than the originals- will provide benefit in terms saving from the public health expenditures will provide advantages in terms of savings. According to the impression we have obtained from clinical practice and research data, we believe that the generics which are manifactured under control and cover the necessary rules, are as effective as the originals. On the other hand, limited clinical observations with some generics may justify the doubts of the clinicians. We believe that these doubts can be eliminated by the strict control conducted by the regulators in the light of feedback obtained from the clinicians.
- Subjects
GENERIC drug substitution; DRUG efficacy; PATENT law; HEALTH insurance; PUBLIC spending; SAVINGS; PHYSICIAN practice patterns
- Publication
Klinik Psikofarmakoloji Bulteni, 2009, Vol 19, Issue 3, p211
- ISSN
1017-7833
- Publication type
Article